GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is now becoming a prominent focus in healthcare investigation, largely due to its remarkable impact on controlling ailments such as type 2 diabetes and obesity. Ongoing studies have demonstrated that beyond glucose management, GLP-1 medi